Y-mabs announces proposed public offering of common stock

Y-mabs announces proposed public offering of common stock.y-mabs therapeutics, - intends to grant underwriters 30-day option to purchase up to $18.75 million in shares of common stock.y-mabs therapeutics - commencement of underwritten public offering of up to $125 million shares.
YMAB Ratings Summary
YMAB Quant Ranking